Panacea Biotec has informed that the landmark collaboration with Refana Inc. USA for Covid-19 vaccine which will enable global development, manufacturing and distribution of the Covid-19 vaccine. Under the collaboration, the company is advancing its response to address the unprecedented challenges of COVID-19 by collaborating with Refana Inc. USA to make Covid-19 vaccine widely accessible around the world in an equitable manner through a Joint Venture company to be based in Ireland. The company has informed that it has enclosed a copy of the Press Release on 10th June 2020 titled ‘Panacea Biotec and Refana announce landmark collaboration for Covid-19 vaccine’ being issued to the media.
The above information is a part of company’s filings submitted to BSE.
